09/19/2010

Use of Hormone Therapy in Breast Cancer Prevention


Recent studies have shown that the long-term use of hormone therapy (often used for menopausal symptoms) show an increased risk for contracting breast cancer.  Those taking the drug should discuss other options with their physician.  If you do decide it’s best for you to continue with the drug however, at least consider lowering the dosage or switching to a temporary (not long-term) usage of it.  While taking the drug may reduce extremely unpleasant menopausal symptoms, it might not be worth the risk that it comes with vis-à-vis the possibility of contracting breast cancer. There are other options available, including alternative remedies that won’t come with these added complications so it is definitely worth investigating the successes of these.  The Women’s Cancer Research Fund – of which Jamie Tisch  is a co-founder – is constantly looking toward better methods and ways of reducing the potential of contracting breast cancer.
Sep 19, 2010 2:24:01 AM | cancer research, charity, Jamie Tisch

The comments to this entry are closed.

NEXT POST
Pantene Helping the Women’s Cancer Research Fund with Jamie Tisch The Women’s Cancer Research Fund, co-founded by Kelly Chapman Meyer, Marion Laurie, Anne Douglas, Quinn Ezralow and Jamie Tisch, relies on the generous donations of many to continue doing their important work. One of their major donors is Pantene, the famous hair care product company. Pantene started in 1947 and was owned by a Swiss drug company Hoffman-LaRoche. Pantene arrived in the United States in the 1960s and continued its popularity there. In the 1980s they had some of the most popular campaigns ever, including the “Don’t hate me because I’m beautiful” campaign. They were purchased by Procter and Gamble in 1985 and they expanded their distribution on a massive scale at that time. By 1995, they had become a billion dollar brand and, today, they have over 100 hair care and hair styling products. Certainly, the Women’s Cancer Research Fund with Jamie Tisch appreciates the support of Pantene to help in the fight against women’s cancers.
PREVIOUS POST
Breast Cancer Gene People often talk about the breast cancer gene, but what exactly is it and what does it mean? Well, the basic finding is that the genes breast cancer are most associated with are: BRCA1 and BRCA2 (otherwise known as Breast Cancer Gene One and Two). These genes – when functioning healthily – have the task of keeping breast cells growing at a normal rate while preventing cancer cell growth. But when abnormalities occur in these genes, there is an increased risk of contracting breast cancer. Still, the gene only accounts for around 10% of all cases of breast cancers. Also remember that most women who contract breast cancer do not have a familial history of the disease. Nonetheless, the fact that research centers have made such progress in the identification of BRCA1 and BRCA2 has resulted in the development of new ways of treating and detecting breast cancer. Jamie Tisch is one of the co-founders of the Women’s Cancer Research Fund, an organization working tirelessly to fight this disease.